REQUEST A DEMO
Total
USD $0.00
Search more companies

Inversiones Endolap S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Inversiones Endolap S.A.S. Profile Updated: August 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Inversiones Endolap S.A.S. is a company in Colombia, with a head office in Cartagena. The enterprise currently operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on July 07, 2017. It currently has a total number of 4 (2024) employees. From the latest financial highlights, Inversiones Endolap S.A.S. reported a net sales revenue increase of 79.11% in 2023. A growth of 20.13% was recorded in its total assets. Inversiones Endolap S.A.S.’s net profit margin increased by 6.48% in 2023.

Headquarters
Conjunto R. Villa de los Alpes Mc - L2 Barrio Los Alpes
Cartagena; Bolivar;

Contact Details: Purchase the Inversiones Endolap S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Inversiones Endolap S.A.S. report to view the information.
Outstanding Shares:
Purchase the Inversiones Endolap S.A.S. report to view the information.
Incorporation Date:
July 07, 2017
Key Executives
Company Performance
Financial values in the chart are available after Inversiones Endolap S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
79.11%
Total operating revenue
79.11%
Operating profit (EBIT)
278.98%
Net Profit (Loss) for the Period
178.29%
Total assets
20.13%
Total equity
12.32%
Operating Profit Margin (ROS)
5.47%
Net Profit Margin
6.48%
Return on Equity (ROE)
15.56%
Quick Ratio
-30.89%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?